Skip secondary menu

PD Biomarkers Participant List



PD Biomarkers Strategic Planning Workshop

May 16-18, 2010
Ritz Carlton Hotel Georgetown
Washington, D.C.
Workshop    Agenda    Executive Summary

 


PARTICIPANT LIST

Samuel Agus, M.D.
Abbott Products Operations AG

Alberto Ascherio, M.D.
Professor of Epidemiology and Nutrition
Harvard School of Public Health

Debra Babcock, M.D., Ph.D.
Program Director
Extramural Research Program
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Andrea Baruchin, Ph.D.
Associate Director for NIH Initiatives
Foundation for the National Institutes of Health

James Beck, Ph.D.
Director of Research Programs
Parkinson’s Disease Foundation

Debra Bergstrom, Ph.D.
Program Analyst
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Robert Bowser, Ph.D.
Associate Professor
University of Pittsburgh School of Medicine

Susan Bressman, M.D.
Chair
Department of Neurology
Beth Israel Medical Center

David Brooks, M.D.
Professor
Imperial College London

Neil Buckholtz, Ph.D.
Chief, Dementias of Aging Branch
National Institute on Aging
National Institutes of Health

David Burn, M.D.
Professor
Movement Disorder Neurology
Newcastle University

Sohini Chowdhury, M.A.
Acting Vice President, Research Programs
Michael J. Fox Foundation for Parkinson’s Research

Lorraine Clark, Ph.D.
Assistant Professor
Columbia University

Thomas Comery
Associate Director
Pfizer

Carolyn Compton, M.D., Ph.D.
Director
Office of Biorepositories and Biospecimen Research
National Cancer Institute
National Institutes of Health

Ted Dawson, M.D., Ph.D.
Professor
Johns Hopkins University School of Medicine

David Eidelberg, M.D.
Director
Center for Neuroscience
Feinstein Institute for Medical Research

Tatiana Foroud, Ph.D.
Professor
Indiana University

Mark Frasier, Ph.D.
Associate Director and Team Leader, Research Programs
Michael J. Fox Foundation for Parkinson’s Research

Brandy Fureman, Ph.D.
Program Director, Channels, Synapses and Circuits
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Wendy Galpern, Ph.D.
Program Director, Clinical Trials
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Xiang Gao, M.D., Ph.D.
Instructor and Associate Epidemiologist
Harvard Medical School

David Goldstein, M.D., Ph.D.
Clinical Neurocardiology Section
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Amelie Gubitz, Ph.D.
Program Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Katrina Gwinn, M.D.
Scientific Officer
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Mark Hallett, M.D.
Chief, Human Motor Control Section
Medical Neurology Branch
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Franz Hefti, Ph.D.
Avid Radiopharmaceuticals, Inc.

Steve Hersch, M.D., Ph.D.
Associate Professor
Massachusetts General Hospital
Harvard Medical School

Un Jung Kang, M.D.
Professor
University of Chicago

Petra Kaufmann, M.D.
Director, Clinical Research
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Karl Kieburtz, M.D.
Director, Center for Human Experimental Therapeutics
University of Rochester

Louis Kirby, M.D.
Co-Chair, Biomarkers Working Groups
Coalition Against Major Diseases

Walter Koroshetz, M.D.
Deputy Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Rainer Kuhn, Ph.D.
Head, Neurodegeneration
Novartis

Story Landis, Ph.D.
Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Blair Leavitt, M.D.
Neurologist and Associate Professor in Medical Genetics
Centre for Molecular Medicine and Therapeutics
University of British Columbia

James Leverenz, M.D.
Associate Professor
Veterans Administration Puget Sound Health Care System
University of Washington

Karen Marder, M.D.
Professor of Neurology
Columbia-Presbyterian Medical Center
Columbia University

Ken Marek, M.D.
Senior Scientist
Institute for Neurodegenerative Disorders

William Matthew, Ph.D.
Director, Office of Translational Research
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Tom Montine, M.D., Ph.D.
Alvord Endowed Chair in Neuropathology and Professor of Pathology
University of Washington

Wolfgang Oertel, M.D.
Professor of Neurology
Philipps-Universitat Marburg

Creighton Phelps, Ph.D.
Program Director, Alzheimer’s Centers
National Institute on Aging
National Institutes of Health

Bernard Ravina, M.D.
Associate Professor
University of Rochester

Ian Reynolds, Ph.D.
Director
Merck Research Laboratories

Alexander Runko, Ph.D.
Program Analyst
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Clemens Scherzer, M.D.
Associate Neurologist
Brigham and Women’s Hospital

Mya Schiess, M.D.
Professor
University of Texas Medical School at Houston

Peter Schmidt, Ph.D.
Chief Information Officer and Program Director
National Parkinson Foundation

Mark Shearman, Ph.D.
Vice President
Neurodegeneration Research
EMD Serono Research Institute

Todd Sherer, Ph.D.
Acting Chief Executive Officer
Michael J. Fox Foundation for Parkinson’s Research

Ira Shoulson, M.D.
Professor
University of Rochester

Beth-Anne Sieber, Ph.D.
Program Officer
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Andrew Singleton, Ph.D.
Laboratory of Neurogenetics
National Institute on Aging
National Institutes of Health

Thierry Sornasse, Ph.D.
Director, Biomarker Integration
Elan Pharmaceuticals, Inc.

David Standaert, M.D., Ph.D.
Professor
University of Alabama at Birmingham

Margaret Sutherland, Ph.D.
Program Director
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Carlie Tanner, M.D., Ph.D.
Clinical Research Director
Parkinson’s Institute

Anna Taylor, Ph.D.
Health Program Specialist
National Institute of Neurological Disorders and Stroke
National Institutes of Health

John Trojanowski, M.D., Ph.D.
Director, University of Pennsylvania Institute on Aging
Director, Udall Center
University of Pennsylvania School of Medicine

David Vaillancourt, Ph.D.
Associate Professor
University of Illinois at Chicago

David Weiner, M.D.
Head of Early Development and Neurodegenerative Diseases Research
EMD Serono, Inc.

Janet Woodcock, M.D.
Director
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Jing Zhang, Ph.D.
Associate Professor
University of Washington

Last updated December 23, 2013